Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-04-02 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO GENERAL COUNSEL SECRETARY | 983,589 | $0 | 0 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO GENERAL COUNSEL SECRETARY | 558 | $2.59 | 27,578 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $2.25 | 28,136 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-06 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $2.35 | 28,677 (Direct) | View |
| 2023-06-01 Tax Withholding | 2023-06-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $4.3 | 29,218 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 5:57 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 638 | $5.21 | 27,286 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 5:00 pm | N/A 2033-02-10 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 215,000 | $0 | 215,000 (Direct) | View |
| 2022-12-01 Tax Withholding | 2022-12-02 8:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $7.75 | 27,924 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 25,000 | $0 | 28,465 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:01 pm | N/A 2032-02-11 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-12 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2020-12-02 9:12 pm | 2020-04-02 2030-04-02 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer | 0 | $0 | 506,011 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:32 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP, General Counsel | 104,000 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP, General Counsel | 32,705 | $60 | 0 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP, General Counsel | 4,628 | $59.37 | 32,705 (Direct) | View |